JP2018510153A5 - - Google Patents

Download PDF

Info

Publication number
JP2018510153A5
JP2018510153A5 JP2017548049A JP2017548049A JP2018510153A5 JP 2018510153 A5 JP2018510153 A5 JP 2018510153A5 JP 2017548049 A JP2017548049 A JP 2017548049A JP 2017548049 A JP2017548049 A JP 2017548049A JP 2018510153 A5 JP2018510153 A5 JP 2018510153A5
Authority
JP
Japan
Prior art keywords
agent
pharmaceutical composition
active agent
roflumilast
pde4b2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017548049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018510153A (ja
JP6960855B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/023475 external-priority patent/WO2016154143A1/en
Publication of JP2018510153A publication Critical patent/JP2018510153A/ja
Publication of JP2018510153A5 publication Critical patent/JP2018510153A5/ja
Application granted granted Critical
Publication of JP6960855B2 publication Critical patent/JP6960855B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017548049A 2015-03-20 2016-03-21 Copd及びその他の炎症状態を治療するための組成物及び方法 Expired - Fee Related JP6960855B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562136115P 2015-03-20 2015-03-20
US62/136,115 2015-03-20
PCT/US2016/023475 WO2016154143A1 (en) 2015-03-20 2016-03-21 Compositions and methods for treating copd and other inflammatory conditions

Publications (3)

Publication Number Publication Date
JP2018510153A JP2018510153A (ja) 2018-04-12
JP2018510153A5 true JP2018510153A5 (cg-RX-API-DMAC7.html) 2019-05-09
JP6960855B2 JP6960855B2 (ja) 2021-11-05

Family

ID=56979181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017548049A Expired - Fee Related JP6960855B2 (ja) 2015-03-20 2016-03-21 Copd及びその他の炎症状態を治療するための組成物及び方法

Country Status (6)

Country Link
US (1) US11045456B2 (cg-RX-API-DMAC7.html)
EP (1) EP3270921A4 (cg-RX-API-DMAC7.html)
JP (1) JP6960855B2 (cg-RX-API-DMAC7.html)
CN (1) CN107427500A (cg-RX-API-DMAC7.html)
HK (1) HK1247123A1 (cg-RX-API-DMAC7.html)
WO (1) WO2016154143A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020005938A2 (pt) * 2017-09-27 2020-11-17 University Of Southern California célula imune ou população de células imunes da mesma, célula efetora imune ou célula-tronco, célula que apresenta antígeno, polinucleotídeo recombinante, vetor, composição que compreende uma célula imune efetora ou uma célula-tronco, métodos para produzir uma célula efetora imune que expressa receptor imune de ocorrência não natural, para gerar uma população de células manipuladas por rna, para fornecer imunidade antidoença em um indivíduo, para tratar ou prevenir uma doença associada à expressão de um antígeno, e, uso

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005020958A2 (en) 2003-08-26 2005-03-10 Research Development Foundation Aerosol delivery of curcumin
TW200800997A (en) 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
WO2008051474A1 (en) * 2006-10-19 2008-05-02 The Uab Research Foundation Water soluble curcumin-based compounds
WO2008070616A2 (en) * 2006-12-01 2008-06-12 University Of Utah Research Foundation METHODS AND COMPOSITIONS RELATED TO HIF-1α
SG171779A1 (en) 2008-12-05 2011-07-28 Intermed Discovery Gmbh Inhibitors of hif-1 protein accumulation
US20130172303A1 (en) * 2012-01-03 2013-07-04 Forest Laboratories Holdings Ltd. Roflumilast compositions for the treatment of copd
HK1207573A1 (en) * 2012-04-10 2016-02-05 Georgia State University Research Foundation, Inc. Compositions and methods for treating otitis media and other conditions with inhibitors of cyld

Similar Documents

Publication Publication Date Title
JP2015517489A5 (cg-RX-API-DMAC7.html)
JP2017528507A5 (cg-RX-API-DMAC7.html)
JP2012502037A5 (cg-RX-API-DMAC7.html)
JP2015057436A5 (cg-RX-API-DMAC7.html)
JP2017528503A5 (cg-RX-API-DMAC7.html)
JP2010132695A5 (cg-RX-API-DMAC7.html)
JP2016516808A5 (cg-RX-API-DMAC7.html)
JP2012255026A5 (cg-RX-API-DMAC7.html)
JP2018507914A5 (cg-RX-API-DMAC7.html)
JP2012517987A5 (ja) 吸入用の医薬組成物のfpd特性を設定する方法
JP2012176990A5 (cg-RX-API-DMAC7.html)
JP2011144201A5 (cg-RX-API-DMAC7.html)
AR067639A1 (es) Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente
JP2013126989A5 (cg-RX-API-DMAC7.html)
JP2014510064A5 (cg-RX-API-DMAC7.html)
JP2015534562A5 (cg-RX-API-DMAC7.html)
JP2016510326A5 (cg-RX-API-DMAC7.html)
DOP2014000271A (es) Nueva forma de dosificacion y formulacion de abediterol
JP2015517983A5 (cg-RX-API-DMAC7.html)
HRP20161514T1 (hr) Uporaba derivata pirazola u liječenju akutnih pogoršanja kronične opstruktivne plućne bolesti
JP2016511753A5 (cg-RX-API-DMAC7.html)
JP2015510916A5 (cg-RX-API-DMAC7.html)
JP2009542581A5 (cg-RX-API-DMAC7.html)
JP2017222722A5 (cg-RX-API-DMAC7.html)
JP2015514739A5 (cg-RX-API-DMAC7.html)